Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S7W-04068 · Session 7

Whether its Access to New Medicines Horizon Scanning Advisory Board is currently considering Friedreich’s ataxia and emerging treatments fo…

Answered Asked by Adam Harley LD Lodged 6 Oct 2026

The question

To ask the Scottish Government whether its Access to New Medicines Horizon Scanning Advisory Board is currently considering Friedreich’s ataxia and emerging treatments for the condition, and, if so, which treatments are being monitored.

The answer

Answered by Angela Constance on 19 Oct 2026 · 13 days after it was lodged, on time

The Access to New Medicines Horizon Scanning Advisory Board (HSAB) identifies disruptive medicines which are predicted to have a significant impact on financial and/or service provision and provides recommendations on what will be required for their use should they be accepted for routine use in the NHS in Scotland.The HSAB is not currently assessing any medicines for Friedreich’s Ataxia, however new disease modifying treatments identified through horizon scanning, will be considered in line with established HSAB criteria for disruptive medicines.

In the Official Report

No contribution in the Official Report cites S7W-04068 by reference.